Company Ticker News September 2, 2021Merck (MRK) Stock Sinks As Market Gains: What You Should Know 0 0 Share
Press Release September 1, 2021Merck To Test Oral Antiviral Candidate For Post-Exposure Prophylaxis Of COVID-19 Infection 0 0 Share
Press Release September 1, 2021Merck's (MRK) Keytruda Gets Full Approval for Bladder Cancer 0 0 Share
Press Release September 1, 2021FDA Approves Updated Indication for Merck's KEYTRUDA® (pembrolizumab) for Treatment of Certain Patients With Urothelial Carcinoma (Bladder Cancer) 0 0 Share
Company Ticker News August 25, 2021Merck: An Unsustainable Dividend And 2 Potential Replacements 0 0 Share
Company Ticker News August 16, 2021Pfizer And Merck: Two Long-Term Laggards In A Momentum Market, As Pfizer Gets A Catalyst From Covid-19 0 0 Share
